Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Farnesyl diphosphate synthase pseudogene 4 (FDPSP4) is a human pseudogene related to the functional *farnesyl diphosphate synthase* (FDPS), an enzyme involved in isoprenoid biosynthesis, but FDPSP4 itself does not encode a functional protein product and is categorized as a pseudogene[1]. Pseudogenes such as FDPSP4 are generally nonfunctional remnants of ancestral genes and do not serve as therapeutic targets[1]. **Additional context explaining rationale:** - **Is_target:** Pseudogenes by definition do not encode active proteins and are not considered functional therapeutic targets such as receptors, enzymes, or transporters[1]. The function and druggability described for farnesyl diphosphate synthase (FDPS) do not apply to the pseudogene FDPSP4. - **Is_incorrect:** The request is for a drug discovery target, but FDPSP4 is not itself a target. Confusion may arise due to the close naming with the functional enzyme (FDPS), which *is* a well-studied therapeutic target, notably for drugs affecting bone resorption and cancer via the mevalonate pathway[3][4]. However, FDPSP4 is a pseudogene without therapeutic or biological function[1].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Farnesyl diphosphate synthase pseudogene 4 (FDPSP4).